SpringerPlus

Table 2 Effect of UFD on oral glucose tolerance test

From: Enhanced glycemic control, pancreas protective, antioxidant and hepatoprotective effects by umbelliferon-α-D-glucopyranosyl-(2^I → 1^II)-α-D-glucopyranoside in streptozotocin induced diabetic rats

S. No.	Groups	Time (min)
		0	30	60	90	120	150
1	Glucose Control	81.6 ± 1.208	154.6 ± 1.965	143.8 ± 1.158	133.2 ± 1.463	120.2 ± 1.655	110.6 ± 1.435
2	UFD (10 mg/kg)	82.4 ± 1.435	140 ± 1.517	133 ± 0.836	126.2 ± 2.289	111.4 ± 0.923	99.8 ± 0.861
3	UFD (20 mg/kg)	81.6 ± 1.077^ns	130.4 ± 1.991^ns	121 ± 1.817^*	112 ± 1.517^**	97.4 ± 0.927^***	84.6 ± 1.536^***
4	UFD (40 mg/kg)	82.2 ± 1.881^ns	121.4 ± 1.503^**	112 ± 1.517^***	99.6 ± 1.208^***	82 ± 2.001^***	62.6 ± 1.327^***
5	Glibenclamide (10 mg/kg)	81 ± 1.581^ns	125 ± 0.707^**	116.4 ± 0.509^**	103 ± 0.717^***	85.8 ± 1.158^***	69.6 ± 1.248^***

All values represent mean ± SEM * P < 0.05; ** P < 0.01; *** P < 0.001, ns < non significant; ANOVA, followed by Dunnett’s multiple comparison test.

Back to article page